期刊名称：TOXICOLOGIC PATHOLOGY ISSN： 0192-6233 出版频率： Bi-monthly 出版社： SAGE PUBLICATIONS INC, 2455 TELLER RD, THOUSAND OAKS, USA, CA, 91320   出版社网址： http://www.tandf.co.uk/ 影响因子： 1.902 主题范畴： PATHOLOGY;    TOXICOLOGY 期刊简介(About the journal)    投稿须知(Instructions to Authors)    编辑部信息(Editorial Board)    About the journal Toxicologic Pathology, the official journal of the Society of Toxicologic Pathology, in now published by SAGE. The journal is now available electronically on SAGE Journals Online at http://tpx.sagepub.com.  Toxicologic Pathology focuses on the multidisciplinary elements that constitute toxicologic pathology, including spontaneous and experimentally induced morphological and functional changes, environmental exposures, case reports, and risk assessment and investigative techniques. The journal publishes original articles, symposia papers, brief communications, current topic reviews, current issues, and fast-track articles. Thomson Reuters 2007 Journal Citation Reports?/P> 2007 Ranking: 28/66 in Pathology 40/73 in Toxicology 2007 Impact Factor: 1.897   Instructions to Authors nstructions to Authors Manuscript Submission Toxicologic Pathology prefers to receive all manuscript submission electronically via Manuscript Central. Manuscript Central is located at http://mc.manuscriptcentral.com/toxpath. Manuscript Central allows for rapid and easy submission of original and revised manuscripts, as well as reviewing and internal communication between authors, editors and reviewers via a web-based platform. prefers to receive all manuscript submission electronically via Manuscript Central. Manuscript Central is located at http://mc.manuscriptcentral.com/toxpath. Manuscript Central allows for rapid and easy submission of original and revised manuscripts, as well as reviewing and internal communication between authors, editors and reviewers via a web-based platform. More details please see the PDF file below.   Instructions to Authors 0192-6233.pdf .pdf Editorial Board    Editorial Board:  Wayne I. Anderson, DVM. PhD Wyeth Research, NY   Susan A. Elmore, MS, DVM NIEHS, NC   Nancy Everds, DVM Amgen Inc., WA   Željko Ferencic, MD GSK Research Institute Zagreb Ltd., Croatia   Kathy Gabrielson, DVM, PhD, ACVP Johns Hopkins University, MD   Takanori Harada, DVM., PhD The Institute of Environmental Toxicology, Japan   Gordon C. Hard, BVSc, PhD, DSc Consultant   Ronald A. Herbert, DVM, PhD NIEHS, NC   Christopher Houle, DVM, PhD Pfizer Inc., CT   Kyle Kolaja, PhD Roche Palo Alto, CA   Patricia Losco, VMD Schering-Plough Research Institute, NJ   Sunao Manabe, DVM, PhD Daiichi Sankyo Co., Ltd., Japan   Elizabeth F. McInnes, BVSc, PhD, FRCPath, MRCVS Huntingdon Life Sciences, UK   Jenny McKay, MVB, PhD AstraZeneca R&D Alderley Park, UK   Colin McKerlie, DVM, DVSc The Hospital for Sick Children, Canada   Odete R. Mendes, DVM, PhD, DACVP Sanofi-aventis Pharma, NJ   Terry Peters, DVM Food & Drug Administration CDER, MD   Ian Pyrah, BVM&S, PhD, MRCVS, MRCPath Amgen Inc., CA   Shashi K. Ramaiah, DVM, OhD Pfizer-DSRD, MO   Cheryl Scudamore, PhD GlaxoSmithKline, UK   Ruud Woutersen TNO Business Unit Quality & Safety, The Netherlands  Inc., WA   Željko Ferencic, MD GSK Research Institute Zagreb Ltd., Croatia   Kathy Gabrielson, DVM, PhD, ACVP Johns Hopkins University, MD   Takanori Harada, DVM., PhD The Institute of Environmental Toxicology, Japan   Gordon C. Hard, BVSc, PhD, DSc Consultant   Ronald A. Herbert, DVM, PhD NIEHS, NC   Christopher Houle, DVM, PhD Pfizer Inc., CT   Kyle Kolaja, PhD Roche Palo Alto, CA   Patricia Losco, VMD Schering-Plough Research Institute, NJ   Sunao Manabe, DVM, PhD Daiichi Sankyo Co., Ltd., Japan   Elizabeth F. McInnes, BVSc, PhD, FRCPath, MRCVS Huntingdon Life Sciences, UK   Jenny McKay, MVB, PhD AstraZeneca R&D Alderley Park, UK   Colin McKerlie, DVM, DVSc The Hospital for Sick Children, Canada   Odete R. Mendes, DVM, PhD, DACVP Sanofi-aventis Pharma, NJ   Terry Peters, DVM Food & Drug Administration CDER, MD   Ian Pyrah, BVM&S, PhD, MRCVS, MRCPath Amgen Inc., CA   Shashi K. Ramaiah, DVM, OhD Pfizer-DSRD, MO   Cheryl Scudamore, PhD GlaxoSmithKline, UK   Ruud Woutersen TNO Business Unit Quality & Safety, The Netherlands